While the technology sector faces a renewed wave of volatility driven by artificial intelligence (AI) scare trades and valuation concerns, a different story is unfolding in the healthcare sector. Investors fleeing the jittery price swings of high-growth tech stocks are finding shelter in a familiar name that is quietly outperforming. Johnson & Johnson (NYSE: JNJ) is trading near all-time highs of approximately $245 per share, creating a divergence that has caught Wall Street's attention.
This rally defies the common perception of the healthcare giant as a slow-moving, boring stock. Over the last 30 days, shares have climbed approximately 14%, significantly outperforming the broader market during a period of uncertainty. This price action suggests that institutional money is rotating out of riskier assets and placing a premium on stability, reliable cash flow, and operational execution.
